ALGOS PHARMACEUTICAL CORP
SC 13G, 1998-02-17
PHARMACEUTICAL PREPARATIONS
Previous: STEINBERG LAWRENCE E, SC 13G, 1998-02-17
Next: ALGOS PHARMACEUTICAL CORP, SC 13G, 1998-02-17












<PAGE>
 
<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                  SCHEDULE 13G
                                 (Rule 13d-102)
             Information Statement Pursuant to Rules 13d-1 and 13d-2
                    Under the Securities Exchange Act of 1934



                        ALGOS PHARMACEUTICAL CORPORATION
                                (Name of Issuer)



                     COMMON STOCK, PAR VALUE $.01 PER SHARE
                         (Title of Class of Securities)



                                   015869 10 0
                                 (CUSIP Number)






                                Page 1 of 5 pages




<PAGE>
 
<PAGE>



                                       13G

CUSIP NO.      015869 10 0
               -----------

1.      NAME OF REPORTING PERSON:
                Roger H. Kimmel
             -------------------------------------------------------------------

2.      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                           (a) [ ]
                                                           (b) [ ]

3.      SEC USE ONLY

4.      CITIZENSHIP OR PLACE OF ORGANIZATION:
                 United States citizen
             -------------------------------------------------------------------

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON
WITH:

5.      SOLE VOTING POWER:
                                            269,666
                       ---------------------------------------------------------

6.      SHARED VOTING POWER:
                                              657,193
                       ---------------------------------------------------------

7.      SOLE DISPOSITIVE POWER:
                                          269,666
                       ---------------------------------------------------------

8.      SHARED DISPOSITIVE POWER:
                                               657,193
                       ---------------------------------------------------------

9.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
        PERSON:
                                       926,859
                       ---------------------------------------------------------

10.     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
        CERTAIN SHARES:
                              [ ]

11.     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9:  5.8%
                       ---------------------------------------------------------

12.     TYPE OF REPORTING PERSON:
                               IN
                       ---------------------------------------------------------




                                Page 2 of 5 pages





<PAGE>
 
<PAGE>



ITEM 1.

        (a)    Name of Issuer:  Algos Pharmaceutical Corporation

        (b)    Address of Issuer's Principal Executive Offices:

                        Collingwood Plaza, 4900 Route 33
                        Neptune, New Jersey 07753-6804

ITEM 2.

        (a)    Name of Person Filing:  Roger H. Kimmel

        (b)    Address of Principal Business Office:

                        Algos Pharmaceutical Corporation
                        Collingwood Plaza, 4900 Route 33
                        Neptune, New Jersey 07753-6804

        (c)    Citizenship:  United States

        (d)    Title of Class of Securities:

                        Common Stock, $.01 par value

        (e)    CUSIP Number:  015869 10 0

ITEM 3.        Not applicable.

ITEM 4.        OWNERSHIP

        (a)    Amount Beneficially Owned:  926,859

        (b)    Percent of Class:  5.8%

        (c)    Number of shares as to which such person has:

               (i)           sole power to vote or to direct the vote:
                                               269,666
                             ---------------------------------------------------

               (ii)          shared power to vote or to direct the vote:
                                                  657,193
                             ---------------------------------------------------

               (iii)         sole power to dispose or to direct the
                             disposition of:
                                                269,666
                             ---------------------------------------------------

               (iv)          shared power to dispose or to direct the
                             disposition of:
                                                   657,193
                             ---------------------------------------------------





                                Page 3 of 5 pages






<PAGE>
 
<PAGE>




ITEM 5.        OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

               Not applicable.

ITEM 6.        OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
               ANOTHER PERSON:

               Of the shares reported by Mr. Kimmel, 657,193 shares are held in
               the Kimmel Family Trust for which Mr. Kimmel serves as a trustee
               and as to which shares Mr. Kimmel holds the shared power of
               disposition and power to vote, and 221,333 shares are held in a
               separate trust as to which Mr. Kimmel serves as the sole trustee
               and as to which shares Mr. Kimmel disclaims beneficial ownership.

ITEM 7.        IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY
               WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
               PARENT HOLDING COMPANY:

               Not applicable.

ITEM 8.        IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
               GROUP:

               Not applicable.

ITEM 9.        NOTICE OF DISSOLUTION OF GROUP:

               Not applicable.

ITEM 10.       CERTIFICATION:

               Not applicable.




                                Page 4 of 5 pages







<PAGE>
 
<PAGE>




                                    SIGNATURE

               After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.

Date:   February 13, 1998




                                            \s\ Roger H. Kimmel
                                           _____________________________________
                                            Roger H. Kimmel







                                Page 5 of 5 pages





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission